Skip to main content

Table 1 Demographic and treatment characteristics of AA and non-AA women with symptomatic uterine fibroids treated by MRgFUS

From: MR-guided focused ultrasound (MRgFUS) is effective for the distinct pattern of uterine fibroids seen in African-American women: data from phase III/IV, non-randomized, multicenter clinical trials

Characteristics AA (n= 63) Non-AA (n= 59) pvaluea
Age    0.001
 Mean (SD) 43.4 (5.1) 46.3 (4.1)
 Median (Q1–Q3) 44.0 (40.0–47.0) 46.0 (44.0–49.0)
 Min.–max. 34.0–53.0 38.0–53.0
Body mass index (kg/m2)    0.03
 Mean (SD) 27.7 (4.9) 25.9 (4.2)
 Median (Q1–Q3) 27.3 (24.1–30.6) 25.3 (22.5–28.4)
 Min.–max. 18.2–40.7 19.1–39.5
Total number of fibroids    <0.001
 Mean (SD) 7.2 (5.4) 2.8 (2.3)
 Median (Q1–Q3) 6.0 (3.0–10.0) 2.0 (1.0–4.0)
 Min.–max. 1.0–30.0 1.0–11.0
Total volume of fibroids (cm3)    <0.001
 Mean (SD) 273.0 (216.0) 449.6 (299.6)
 Median (Q1–Q3) 196.9 (112.8–415.3) 394.8 (189.8–674.4)
 Min.–max. 15.7–807.2 18.1–1518.4
Number of treated fibroids    0.01
 Mean (SD) 1.6 (0.8) 1.3 (0.6)
 Median (Q1–Q3) 1.0 (1.0–2.0) 1.0 (1.0–1.0)
 Min.–max. 1.0–4.0 1.0–4.0
Total volume of treated fibroids (cm3)    <0.001
 Mean (SD) 177.9 (162.4) 408.5 (286.6)
 Median (Q1–Q3) 130.0 (64.6–235.0) 366.6 (183.7–564.0)
 Min.–max. 15.7–700.0 18.1–1518.4
NPV ratio per total fibroid    0.52
 Mean (SD) 28.2 (20.0) 26.3 (20.7)
 Median (Q1–Q3) 26.0 (15.3–41.0) 21.0 (9.0–42.0)
 Min.–max.ds 0.0–81.4 0.0–79.0
NPV ratio per treated fibroid    0.03
 Mean (SD) 40.6 (25.4) 29.9 (23.8)
 Median (Q1-Q3) 37.6 (25.6–55.1) 27.3 (9.3–48.0)
 Min.–max. 0.0–91.2 0.0–94.0  
  1. aTwo-sided Mann–Whitney-Wilcoxon p values. NPV non-perfused volume.